Article
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses counseling points for OIC patients.
Mary M. Bridgeman, PharmD, BCPS, CGP, discusses counseling points for OIC patients.
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval
2 Commerce Drive
Cranbury, NJ 08512